Last reviewed · How we verify

NCT06634134

Cycling Through the Menstrual Cycle

Recruiting now Last updated 28 July 2025
What this trial tests

trial testing Adjusting training advice in Menstrual Cycle-based Periodized Training in 750 participants. Currently enrolling.

Timeline
10 October 2024
Primary endpoint
1 January 2026
1 January 2028

Quick facts

Lead sponsorMartini Hospital Groningen
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment750
Start date10 October 2024
Primary completion1 January 2026
Estimated completion1 January 2028
Sites2 locations across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Martini Hospital Groningen

Who can join

Adults 12 to 60, female only, with Menstrual Cycle-based Periodized Training or Female Athlete Triad. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

With an increase in number of female athletes in sport events, it is becoming more important to gain insight in female related sports physiology. A main difference between male anf female athletes is the menstrual cycle. During the menstrual cycle, female reproductive hormones fluctuate. These hormones are also of influence on endurance, recovery, muscle strenght and mental state. Therefore we hypothesize that training efficiancy, power and motivation to train differ during the menstrual cycle. In case there is a pattern seen during the menstrual cycle, training programs can be individualized taking the menstrual cycle into account leading to more effective training programs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Martini Hospital Groningen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06634134.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing